Anavex Life Sciences is a New York biopharmaceutical company developing drug candidates for Alzheimer's and other brain diseases. AVXL reports earnings on Tue, Nov 24, 2026.
Earnings
Earnings calendar →Seasonality
How AVXL has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
Whale Options Flow
90DNo whale options trades in AVXL in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AVXL is in one of them and how their past AVXL trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered AVXL in an article yet. Here's the latest on the wider market.
AVXL Congress Trades
All congress trades →
| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Christopher JacobsR · NY | Sell | $1K – $15K | Dec 12, 2022 | Jan 20, 2023 | 39 d |
| Christopher JacobsR · NY | Buy | $1K – $15K | Oct 12, 2022 | Nov 16, 2022 | 35 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Anavex Life Sciences
Anavex Life Sciences is a clinical stage biopharmaceutical company based in New York. It develops drug candidates for diseases of the central nervous system, including Alzheimer's disease, Parkinson's disease, schizophrenia, Rett syndrome and other rare brain disorders. Its main candidate, blarcamesine, is being studied as an oral treatment that acts on the sigma receptor. The company's intended customers are patients with these conditions and the healthcare providers who treat them.
- Headquarters
- New York, NY